Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10137204 Anti-DLL3 antibody drug conjugates for treating cancer
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
September 15, 2016
Date of Patent
November 27, 2018
Patent Application Number
15266894
Patent Citations Received
US Patent 12084518 Trispecific binding proteins and methods of use
0
US Patent 10308721 Anti-DLL3 antibodies and drug conjugates for use in melanoma
0
US Patent 11976125 B cell maturation antigen binding proteins
0
Patent Inventor Names
David Liu
0
Orit Foord
0
Robert A. Stull
0
Scott J. Dylla
0
Hui Shao
0
Laura Saunders
0
Michael Torgov
0
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
10137204
Patent Primary Examiner
Christine J. Saoud
Find more entities like US Patent 10137204 Anti-DLL3 antibody drug conjugates for treating cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE